Admission C-reactive protein does not predict functional outcomes in patients with strokes in a subacute rehabilitation unit

American Journal of Physical Medicine and Rehabilitation

Volumn 87, Issue 9, 2008, Pages 731-739

  Rabadi, Meheroz H ^a   Coar, Patricia L ^a   Lukin, Meredith ^b,c   Lesser, Martin ^b,c   Blass, John P ^c,d  

^a BURKE REHABILITATION HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Nutrition; Outcome; Rehabilitation; Stroke

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; REHABILITATION CARE; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TREATMENT DURATION; VISUAL FIELD; BLOOD; CONVALESCENCE; DISABILITY; HOSPITAL SUBDIVISIONS AND COMPONENTS; INFECTION; LENGTH OF STAY; PROSPECTIVE STUDY;

AGED; C-REACTIVE PROTEIN; DISABILITY EVALUATION; FEMALE; HOSPITAL UNITS; HUMANS; INFECTION; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PATIENT DISCHARGE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SERUM ALBUMIN; STROKE; TRANSFERRIN;

EID: 52449087770     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31818380ae     Document Type: Article

References (51)

1. Ridker PM, Buring JE, Shih J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3
2. Ridker PM, Hennekens CH, Buring JE, et al: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43
3. Ridker PM, Rifai N, Rose L, et al: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65
4. Pradhan AD, Manson JE, Rossouw JE, et al: Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-7
5. Rost NS, Wolf PA, Kase CS, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32:2575-9
6. Curb JD, Abbott RD, Rodriguez BL, et al: C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003;107: 2016-20
7. Cao JJ, Thach C, Manolio TA, et al: C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. Circulation 2003; 108:166-70
8. Wakugawa Y, Kiyohara Y, Tanizaki Y, et al: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population. Stroke 2006;37:27-32
9. Ridker PM, Cushman M, Stampfer MJ, et al: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8
10. Di Napoli M, Papa F; Villa Pini Stroke Data Bank Investigators: Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemie stroke patients. Stroke 2002;33:1763-71
11. Tanne D, Benderly M, Goldbourt U, et al: C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006;37:1720-4
12. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-8
13. Audebert HJ, Rott MM, Eck T, et al: Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 2004;35:2128-33
14. Muir KW, Weir CJ, Alwan W, et al: C-reactive protein and outcome after ischemie stroke. Stroke 1999;30: 981-5
15. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemie stroke: an independent prognostic factor. Stroke 2001;32:917-24
16. Torzewski J, Torzewski M, Bowyer DE, et al: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-92
17. Paul A, Ko KW, Li L, et al: C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109: 647-55
18. Torzewski M, Rist C, Mortensen RF, et al: C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094-9
19. Cermak J, Key NS, Bach RR, et al: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20
20. Ebeling P: Monocyte tissue factor induction by C-reactive protein and relationship with hormone replacement treatment. Circulation 2001;103:E49
21. Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7
22. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20
23. Hattori Y, Matsumura M, Kasai K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003;58:186-95
24. Wang CH, Li SH, Weisel RD, et al: C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003;107:1783-90
25. Verma S, Wang CH, Li SH, et al: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9
26. Venugopal SK, Devaraj S, Yuhanna I, et al: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41
27. Fichtlscherer S, Kaszkin M, Breuer S, et al: Elevated secretory non-pancreatic type II phospholipase A2 serum activity is associated with impaired endothelial vasodilator function in patients with coronary artery disease. Clin Sci (Lond) 2004;106:511-7
28. Cleland SJ, Sattar N, Petrie JR, et al: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) 2000;98:531-5
29. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8
30. Pasceri V, Cheng JS, Willerson JT, et al: Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103:2531-4
31. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State. J Psychiatr Res 1975;12:189-98
32. Desmond DW, Moroney JT, Paik MC, et al: Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000;54:1124-31
33. Lin JH, Lin RT, Tai CT, et al: Prediction of poststroke dementia. Neurology 2003;61:343-8
34. Sunderland A, Tinson D, Bradley L, et al: Arm function after stroke: an evaluation of grip strength as a measure of recovery and prognostic indicator. J Neuro Neurosurg Psych 1989;52:1267-72
35. Cameron D, Bohannon RW: Criterion validity of lower extremity Motricity Index scores. Clin Rehabil 2000;14:208-11
36. Collin C, Wade D: Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry 1990;53:576-9
37. Yarnell PR, Friedman BB: Left "hemi"ADL learning and outcome: limiting factors. J Neurol Rehabil 1987;1:125-30
38. Reding MJ, Potes E: Rehabilitation outcome following initial unilateral hemispheric stroke: life table analysis approach. Stroke 1988;19:1354-8
39. Tomasello F, Mariani F, Fieschi C, et al: Assessment of inter-observer differences in the Italian multicenter study on reversible cerebral ischemia. Stroke 1982;13:32-5
40. Granger CV: The emerging science of functional assessment: our tool for outcomes analysis. Arch Phys Med Rehabil 1998;79:235-40
41. Stineman MG, Shea JA, Jette A, et al: The functional independence measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil 1996;77: 1101-8
42. Stineman MG, Maislin G: Validity of functional independence measure scores. Scand J Rehabil Med 2000;32:143-4
43. Wilson DB, Houle DM, Keith RA: Stroke rehabilitation: a model predicting return home. West J Med 1991;154: 587-90
44. Ancheta J, Husband M, Law D, et al: Initial functional independence measure score and interval post stroke help assess outcome, length of hospitalization, and quality of care. Neurorehabil Neural Repair 2000;14:127-34
45. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7
46. Di Napoli M, Papa F, Bocola V: Periodontal disease, C-reactive protein, and ischemic stroke. Arch Intern Med 2001;161:1234-5
47. Emsley HC, Smith CJ, Gavin CM, et al: An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003;139:93-101
48. Ladenvall C, Jood K, Blomstrand C, et al: Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37: 2018-23
49. Agmon Y, Khandheria BK, Meissner I, et al: C-reactive protein and atherosclerosis of the thoracic aorta: a population-based transesophageal echocardiographic study. Arch Intern Med 2004;164:1781-7
50. Smith CJ, Emsley HC, Gavin CM, et al: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004;4:2
51. Winbeck K, Poppert H, Etgen T, et al: Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002;33: 2459-64